Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210033037 210009733 1.76 74.7 Curative (C) 2017-02-08 2017-03-18 Temozolomide + RT N Y 210019691 TEMOZOLOMIDE + RT
210033039 210009778 null 85.9 Curative (C) 2013-02-16 2014-01-27 Trial Unspecified Y N 210019845 TRIAL
210033040 210009783 0 75 Curative (C) 2016-02-12 2016-02-21 Temozolomide + RT N Y 210019855 TEMOZOLOMIDE + RT
210033041 210020231 1.8 62 Curative (C) 2015-09-03 2015-09-17 Temozolomide + RT 02 null 210019894 TEMOZOLOMIDE + RT
210033042 210009800 1.7 null Curative (C) 2016-07-21 2016-07-23 Trial Unspecified 1 N 210019904 TRIAL
210033043 210009802 1.7 76 null 2016-06-26 2016-07-18 Temozolomide + RT null null 210019905 TEMOZOLOMIDE + RT
210033045 210009824 1.73 17.8 Palliative (P) 2018-02-06 2018-03-02 Temozolomide + RT N null 210019979 TEMOZOLOMIDE + RT
210033046 210026983 null 63 Curative (C) 2018-10-31 2018-11-19 Temozolomide + RT N null 210020022 TEMOZOLOMIDE + RT
210033047 210009864 1.61 107 Disease modification (D) 2015-10-02 2015-10-08 Trial Unspecified 01 Y 210020105 TRIAL
210033048 210009889 1.86 90 Adjuvant (A) 2014-11-25 2014-11-25 Temozolomide + RT N N 210020202 TEMOZOLOMIDE + RT
210033049 210009896 1.77 47 null null 2015-05-31 Trial Unspecified 1 Y 210020262 TRIAL
210033050 210009898 1.6 65.4 Curative (C) 2015-10-12 2015-11-02 Temozolomide + RT N N 210020274 TEMOZOLOMIDE + RT
210033051 210009902 1.66 72.9 Curative (C) 2016-08-25 2016-09-09 Trial Unspecified 01 Y 210020279 TRIAL
210033052 210020315 null 90 Curative (C) 2014-06-07 2014-06-09 CHOP-OR TRIAL 2 null 210020286 TRIAL
210033053 210009910 1.63 null Curative (C) 2015-06-23 2015-07-07 Temozolomide + RT N N 210020306 TEMOZOLOMIDE + RT
210033054 210009917 1.73 91.9 Curative (C) null 2017-12-29 CNS Medbl HR Cyclo+Vinc 2 Y 210020337 TRIAL
210033055 210009920 1.81 109.6 Curative (C) null 2014-02-10 Temozolomide + RT null null 210020338 TEMOZOLOMIDE + RT
210033056 210009923 1.82 31.1 Curative (C) 2015-11-03 2015-11-10 Trial Unspecified Y N 210020354 TRIAL
210033057 210020334 null null Adjuvant (A) 2014-02-23 2014-04-24 ESPHALL TRIAL N null 210020375 TRIAL
210033058 210020334 1.81 66.6 Curative (C) null 2016-10-24 Trial Unspecified 01 Y 210020375 TRIAL
210033059 210009932 0 70.35 Curative (C) 2019-05-01 2019-05-09 Trial Unspecified Y Y 210020401 TRIAL
210033060 210009967 1.73 73 Adjuvant (A) 2015-10-04 2015-10-04 Temozolomide + RT 02 N 210020530 TEMOZOLOMIDE + RT
210033061 210009989 1.19 97 Palliative (P) 2013-11-26 2014-01-27 Temozolomide + RT 02 N 210020606 TEMOZOLOMIDE + RT
210033062 210010014 0 96.3 Adjuvant (A) 2016-09-20 2016-11-25 Temozolomide + RT N Y 210020678 TEMOZOLOMIDE + RT
210033063 210010018 1.72 0 Adjuvant (A) 2018-03-12 2018-03-12 Trial Unspecified 01 null 210020704 TRIAL
210033064 210010023 0 97 Curative (C) 2014-09-30 2014-10-14 Temozolomide + RT N Y 210020737 TEMOZOLOMIDE + RT
210033066 210010036 1.63 58.9 Curative (C) 2018-10-25 2018-11-25 Temozolomide + RT N null 210020797 TEMOZOLOMIDE + RT
210033067 210010039 null 79.4 Curative (C) 2019-02-23 2019-04-20 CNS Medbl HR Cyclo+Vinc 01 Y 210020804 TRIAL
210033068 210010065 1.75 85.9 Curative (C) 2014-06-20 2014-06-21 Trial Unspecified N Y 210020896 TRIAL
210033069 210010077 1.6 77.3 Palliative (P) 2015-04-14 2015-05-23 Temozolomide + RT 02 Y 210020932 TEMOZOLOMIDE + RT
210033070 210010081 1.66 99.3 Curative (C) null 2016-10-12 Temozolomide + RT N N 210020935 TEMOZOLOMIDE + RT
210033071 210010084 null 69.1 Curative (C) 2013-09-21 2013-11-12 Temozolomide + RT N N 210020946 TEMOZOLOMIDE + RT
210033072 210037413 1.71 15.4 Curative (C) null 2014-07-22 Trial Unspecified Y N 210020956 TRIAL
210033073 210010088 null 78.5 null 2016-11-25 2016-11-30 ESPHALL TRIAL null null 210020961 TRIAL
210033074 210010096 1.8 null Palliative (P) 2013-08-01 2013-08-16 Temozolomide + RT N N 210020995 TEMOZOLOMIDE + RT
210033075 210010101 null 101.6 null 2015-08-08 2015-08-29 Temozolomide + RT N null 210021004 TEMOZOLOMIDE + RT
210033076 210030922 null 16.2 Palliative (P) 2017-09-11 2017-11-12 Trial Unspecified 01 null 210021061 TRIAL
210033077 210010118 1.49 90 Curative (C) 2015-12-05 2015-12-19 Temozolomide + RT N N 210021074 TEMOZOLOMIDE + RT
210033079 210020492 null 53.6 Disease modification (D) 2016-04-01 2016-06-03 CNS HGG HERBY Bevacizumab null null 210021081 TRIAL
210033080 210010129 null null Palliative (P) null 2016-06-26 Temozolomide + RT N N 210021134 TEMOZOLOMIDE + RT
210033081 210010137 null 64.5 Curative (C) null 2019-04-24 Temozolomide + RT 02 N 210021164 TEMOZOLOMIDE + RT
210033082 210010141 null 78.9 Neo-adjuvant (N) 2014-11-23 2015-04-05 Trial Unspecified N N 210021183 TRIAL
210033083 210010144 1.28 0 Curative (C) 2016-02-10 2016-02-10 Trial Unspecified Y null 210021185 TRIAL
210033086 210020522 null 59.5 Disease modification (D) 2016-05-19 2016-05-21 Trial Unspecified Y N 210021232 TRIAL
210033087 210020525 1.51 53.6 Disease modification (D) 2014-06-17 2014-06-18 Trial Unspecified Y Y 210021237 TRIAL
210033088 210020531 1.72 74.3 Curative (C) 2018-05-22 2018-10-03 Trial Unspecified 1 Y 210021253 TRIAL
210033089 210010177 null 48 Curative (C) null 2019-11-14 Temozolomide + RT null null 210021285 TEMOZOLOMIDE + RT
210033090 210020544 1.7 68.7 Palliative (P) 2015-08-18 2015-08-23 Trial Unspecified 1 null 210021292 TRIAL
210033091 210010191 1.79 76.2 Unknown (U) 2018-08-11 2018-08-27 Temozolomide + RT 02 N 210021334 TEMOZOLOMIDE + RT
210033092 210010192 1.76 128.3 Disease modification (D) 2014-12-31 2015-03-09 Temozolomide + RT null null 210021338 TEMOZOLOMIDE + RT